日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Protocol for NAC Attack, a phase-3, multicenter randomized, parallel, double masked, placebo controlled trial evaluating the efficacy and safety of oral N-acetylcysteine (NAC) in patients with retinitis pigmentosa

NAC Attack方案是一项3期、多中心、随机、平行、双盲、安慰剂对照试验,旨在评估口服N-乙酰半胱氨酸(NAC)治疗视网膜色素变性患者的疗效和安全性。

Kong, Xiangrong; Ibukun, Folahan; Khan, Muhammad J; Hafiz, Gulnar; Wehling, Dagmar; Dreger, Kurt; Singh, Mandeep; Birch, David; Jaffe, Glenn; Naufal, Fahd; Traboulsi, Elias I; Duncan, Jacque; Hufnagel, Rob; Carroll, Joseph; Lu, Yuchen; Matsui, Rodrigo; Moulton, Lawrence H; Hawkins, Barbara; Campochiaro, Peter A

Locus-Level Changes in Macular Sensitivity in Patients with Retinitis Pigmentosa Treated with Oral N-acetylcysteine

口服N-乙酰半胱氨酸治疗视网膜色素变性患者黄斑敏感度的局部变化

Kong, Xiangrong; Hafiz, Gulnar; Wehling, Dagmar; Akhlaq, Anam; Campochiaro, Peter A

Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular Edema

视网膜静脉阻塞患者因黄斑水肿接受治疗后出现视力峰值丧失

Iftikhar, Mustafa; Mir, Tahreem A; Hafiz, Gulnar; Zimmer-Galler, Ingrid; Scott, Adrienne W; Solomon, Sharon D; Sodhi, Akrit; Wenick, Adam S; Meyerle, Catherine; Jiramongkolchai, Kim; Liu, T Y Alvin; Arevalo, J Fernando; Singh, Mandeep; Kherani, Saleema; Handa, James T; Campochiaro, Peter A

Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein Occlusion

视网膜静脉阻塞中血管内皮生长因子抑制相关的视网膜无灌注变化

Mir, Tahreem A; Kherani, Saleema; Hafiz, Gulnar; Scott, Adrienne W; Zimmer-Galler, Ingrid; Wenick, Adam S; Solomon, Sharon; Han, Ian; Poon, David; He, Lingmin; Shah, Syed Mahmood; Brady, Christopher J; Meyerle, Catherine; Sodhi, Akrit; Linz, Marguerite O; Sophie, Raafay; Campochiaro, Peter A

Interleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGF.

白细胞介素-18 在眼部具有抗渗透性和抗血管生成活性:与 VEGF 相互抑制

Shen Jikui, Choy David F, Yoshida Tsunehiko, Iwase Takeshi, Hafiz Gulnar, Xie Bing, Hackett Sean F, Arron Joseph R, Campochiaro Peter A

Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusion

雷珠单抗治疗视网膜静脉阻塞患者的长期预后;视网膜无灌注进展的作用

Sophie, Raafay; Hafiz, Gulnar; Scott, Adrienne W; Zimmer-Galler, Ingrid; Nguyen, Quan Dong; Ying, Howard; Do, Diana V; Solomon, Sharon; Sodhi, Akrit; Gehlbach, Peter; Duh, Elia; Baranano, David; Campochiaro, Peter A

Topical mecamylamine for diabetic macular edema.

局部应用美卡拉明治疗糖尿病性黄斑水肿

Campochiaro Peter A, Shah Syed Mahmood, Hafiz Gulnar, Heier Jeffery S, Lit Eugene S, Zimmer-Galler Ingrid, Channa Roomasa, Nguyen Quan Dong, Syed Beena, Do Diana V, Lu Lili, Monk James, Cooke John P, Kengatharan M Ken, Hsu Henry H

Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration

静脉注射贝伐单抗可使除年龄相关性黄斑变性以外的其他疾病引起的脉络膜新生血管消退。

Nguyen, Quan Dong; Shah, Syed Mahmood; Hafiz, Gulnar; Do, Diana V; Haller, Julia A; Pili, Roberto; Zimmer-Galler, Ingrid E; Janjua, Kashif; Symons, R C Andrew; Campochiaro, Peter A